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Solid tissue repair or regeneration with stem cells is a 
major challenge that is now motivating studies of many 
cell types with many methods. Th  erapies are typically 
expected to require expansion of autologous or allogeneic 
cells before transplantation into damaged or diseased 
tissue, but an ability to control self-renewal, diﬀ  er  en-
tiation, and expansion of isolated stem cells and their 
progenitors is probably crucial for any successful 
translation to humans. Soluble factors have been the 
usual approach in eﬀ  orts to control stem cells, but Gilbert 
and colleagues show that even transplantation into mice 
will beneﬁ  t from more attention to insoluble factors [1].
Tissue cells are adherent, which engages many signaling 
pathways. Indeed, adhesion extends into a cell beyond its 
membrane, with active engagement of the cytoskeleton: a 
cell constantly probes its micro  environment by physically 
pulling on extracellular matrix and adjacent cells. Such 
forces cause matrix deformations in proportion to matrix 
elasticity; that is, the tendency of your tissue to spring 
back after pinching or pulling it. At the cell level, the 
mechanics feed back and remodel a cell’s cytoskeleton, 
impacting signaling pathways and cell fate. A number of 
recent papers have highlighted the importance of myosin 
contractility in the viability and fate of pluripotent 
embryonic stem cells [2-4]. Th  e coupling of stem-cell-
generated forces to matrix elasticity also aﬀ  ects 
diﬀ  erentiation, with initial results for mesen  chymal stem 
cells indicating that matrix elasticity directs lineage 
speciﬁ  cation [5]. Hematopoietic stem cells cultured on 
soft, elastic substrates expand twofold to threefold 
whereas crosslink rigidiﬁ  cation of the substrate abolishes 
this eﬀ   ect [6]. Matrix stiﬀ   ness indeed varies between 
tissues, and ranges from extremely soft bone marrow and 
brain tissue to rigid calciﬁ  ed bone. Muscle is not too soft 
and not too stiﬀ   , as muscle needs to be suﬃ   ciently 
compliant to change length in contraction. Moreover, 
when there are defects in compliant proteins, such as 
dystrophin [7], muscular dystrophies arise – which 
motivates therapies such as stem cell trans  plantation.
At the microscale relevant to cells, the lateral elasticity 
of normal, ﬂ  accid skeletal muscle has been measured to 
have an elastic modulus of ~12 kPa [8], while rat cardiac 
tissue [9] and mouse cardiac tissue [10] are perhaps stiﬀ  er 
by up to twofold. Such elasticity is typical of many 
polyacrylamide gels widely used in protein separations. 
Gilbert and colleagues reproduced past measurements of 
the tibialis anterior skeletal muscle and then determined 
whether this level of stiﬀ  ness  aﬀ   ects the behavior of 
muscle stem cells (MuSCs) [1]. Hydrogels were 
engineered to have the same elasticity as muscle tissue, or 
else were softer or stiﬀ   er, with laminin basement 
membrane protein integrated into the gels. MuSCs were 
thus cultured on gels of elasticities 2 kPa, 12 kPa, and 
42 kPa, and also on extremely thin gels on plastic so that 
the cells could feel the rigid plastic beneath. Tissue 
culture plastic is about 100,000-fold more rigid than any 
soft tissue.
Surprisingly, MuSCs cultured on 12 kPa gels expanded 
over time and maintained a primitive phenotype, whereas 
MuSCs on rigid substrates did not expand and also 
tended to diﬀ  erentiate. Time-lapse imaging showed that 
while the cells divided at similar rates on both soft and 
rigid substrates, cells on rigid substrates died much more 
frequently. Two transcription factors were assayed to 
stage the cells: Pax7 for MuSCs, and Myogenin for 
Abstract
Almost every laboratory that grows mammalian cells 
today grows their cells on tissue culture plastic, which 
was introduced to cell culture decades ago based 
on properties such as inertness, transparency, and so 
forth. However, plastic is rigid and unlike the many soft 
tissues in the body. Polymer gel systems that mimic the 
softness of various tissues have been developed over 
the past decade to test and understand the eff  ects of 
rigidity on cells such as muscle cells. One recent study 
even shows that muscle stem cells expand much 
better in vitro on muscle-mimetic gels and that such 
cells prove optimal for engraftment in muscle.
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© 2010 BioMed Central Ltddiﬀ   er  entiation. Pax7 was seen in about one-third of 
dividing cell doublets on the 12 kPa matrices, indicating 
sym  metric division and self-renewal; this was about 
ﬁ   vefold higher than doublets on rigid substrate. 
Myogenin immunoﬂ  uorescence also suggested a three-
fold lower expression on the 12 kPa matrices, consistent 
with a less diﬀ  erentiated state. Past studies of mesen  chy-
mal stem cells on ~12  kPa showed that both Pax7 and 
Myogenin were induced but only to levels well below 
myoblasts [5]. Earlier work with myoblasts further demon-
strated that myoblasts would fuse and generate the most 
robustly striated myotubes on 12 kPa matrices compared 
with even 50% softer or 50% stiﬀ  er substrates [8]. Multiple 
in vitro studies have thus demonstrated that 12  kPa 
matrices are best for multiple stages of myogenesis.
Transplantation of matrix-controlled cells was 
therefore the next logical step for the ﬁ  eld. Gilbert and 
colleagues expanded MuSCs on 12 kPa gels for 7 days 
and then injected them into damaged muscle (Figure 1). 
While freshly isolated MuSCs that are immediately 
transplanted into injured muscle tissue engraft best, even 
one cycle of division on rigid plastic prevents any signi-
ﬁ  cant MuSC engraftment. In comparison, just 10 MuSCs 
that had undergone one round of division on 12 kPa gels 
proved suﬃ   cient for 10% above threshold engraftment 
upon transplantation. Growth of MuSCs in vitro for even 
a short time on muscle-mimetic matrix can thus promote 
self-renewal and prolong regenerative potential. Whether 
this material approach to stem cell expansion will apply 
to other progenitor cells needs to be tested. Also in need 
of testing for more lineages than muscle is whether 
matrices can be used to ﬁ  rst direct in vitro diﬀ  erentiation 
of more pluripotent or multipotent stem cells and then 
expand the early progenitors as a method to fully prime 
for implantation. It is nonetheless becoming clear that 
stem cells feel matrix elasticity as a potent insoluble 
factor in proliferation and diﬀ  erentiation.
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Figure 1. Priming cells on rigid plastic versus biomimetic gels.
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